methotrexate accord
accord healthcare b.v. - metotreksatas - koncentratas infuziniam tirpalui - 25 mg/ml; 100 mg/ml - methotrexate
ebetrexat
sandoz d.d. - metotreksatas - injekcinis tirpalas užpildytame švirkšte - 20 mg/ml - methotrexate
methotrexat ebewe
ebewe pharma ges.m.b.h. nfg. kg - metotreksatas - injekcinis ar infuzinis tirpalas - 2,5 mg; 100 mg/ml; 10 mg/ml - methotrexate
methotrexate-teva
teva pharma b.v. - metotreksatas - injekcinis tirpalas - 100 mg/ml - methotrexate
methotrexat-ebewe
lex ano, uab - metotreksatas - tabletės - 5 mg - methotrexate
methotrexate orion
orion corporation - metotreksatas - tabletės - 2,5 mg; 10 mg - methotrexate
methotrexat ebewe
lex ano, uab - metotreksatas - injekcinis tirpalas - 100 mg/ml
nordimet
nordic group b.v. - metotreksatas - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antinavikiniai vaistai - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
trexan
orion corporation - metotreksatas - tabletės - 10 mg; 2,5 mg - methotrexate
metex
medac gesellschaft für klinische spezialpräparate mbh - metotreksatas - injekcinis tirpalas užpildytame švirkštiklyje - 10 mg; 30 mg/0,6 ml; 27,5 mg/0,55 ml; 25 mg/0,5 ml; 22,5 mg/0,45 ml; 20 mg/0,4 ml; 17,5 mg/0,35 ml; 15 mg/0,3 ml; 12,5 mg/0,25 m - methotrexate